• E-mail
• Print
• Comment
• Font Size
• Digg
• del.icio.us
• Discuss article

Research and Markets: Gain Insight into the Current Product Pipeline at ABIOMED Inc. With New Report

Posted on: Wednesday, 12 December 2007, 15:00 CST

Research and Markets (http://www.researchandmarkets.com/reports/c76979) has announced the addition of ABIOMED Inc. - Product Pipeline Report to their offering.

The ABIOMED Inc Latest Product Pipeline Report contains contact information, business summary, company details, selected financial data, detailed product pipeline (including disease hub, description, therapeutic indication, mechanism of action, drug class, current trial information, trial details and partnering detail), product revenue, trademarks, corporate partners and management profiles.

Our products provide an unbiased, accurate, independent approach to company analysis, whether for partnering or investment purposes. They are based on the most comprehensive database of private and public biomedical companies available.

Updated daily, the database covers 8,000 companies, over 24,000 products across 17 therapeutic categories with 700 sub-categories. We distil and systematize pipeline, financial, competitive product, mechanism of action, partnering, and patent information to provide the most comprehensive and up-to-date information available. The ABIOMED Inc Product Pipeline Report therefore delivers the latest and the most comprehensive intelligence available on ABIOMED Incs current pipeline portfolio.

Product Pipeline Reports Business Summary Contact Information Selected Financial Data Company Details Product Glance (Table/Graph) Disease Hub Classification (Table/Graph) Product Pipeline Product Catalog Product Details with Description, Therapeutic Indication, Drug Class, Mechanism of Action, Current Trial, Trial Details, Partnering Details etc. Patent Details (if any) Recent Financings Trademarks Deals & Alliances Management Profile Recent Updates

For more information visit http://www.researchandmarkets.com/reports/c76979

Source: Life Science Analytics

Source: Business Wire

More News in this Category